The trial at UAMS is the first time a breast cancer vaccine has been tested in humans outside of US military families. The human trial trumps research by others---from Dr. Vincent Tuohy in Cleveland to the United States Army.
Doctors at the University of Arkansas for Medical Sciences (UAMS) are done with a Phase I breast cancer vaccine trial. The breast cancer vaccine induced antibody responses in the "small group of participants who received five injections of the vaccine" in 23 weeks.
The Researchers' peptide vaccine was designed to "trigger an immune response that destroys the cancer cells. The peptide (a computer generated chemical compound) "mimics carbohydrates that are attached to the cancer cells and tricks the immune system into attacking those carbohydrates".
The trial at UAMS is the first time a breast cancer vaccine has been tested in humans outside of US military families. The human trial trumps research by others---from Dr. Vincent Tuohy in Cleveland to the United States Army. Phase II of the trial begins in the "next few months to examine if the vaccine improves the efficacy of preoperative chemotherapy."
Read more here: http://www.examiner.com/article/uams-tests-breast-cancer-vaccine-on-humans
Photo source: http://xenophilius.wordpress.com/2008/09/15/new-vaccine-fights-breast-cancer-tumors/
Photo compilation: LM
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Con la incorporación de Sanitas y las suscripciones ya firmadas con a...
